Monopar Therapeutics Inc. buy Midas
Start price
24.10.20
/
50%
€4.00
Target price
04.11.21
-
Performance (%)
37.50%
End price
26.01.21
€5.50
Summary
This prediction ended on 26.01.21 with a price of €5.50. With a performance of 37.50% the BUY prediction by Midas was a big success. Midas has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Monopar Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | 3,01 % | 1,44 % | 22,85 % | 50,83 % |
| iShares Nasdaq 100 | 3,01 % | 0,57 % | 37,06 % | 80,37 % |
| iShares Nikkei 225® | 4,14 % | 4,55 % | 53,86 % | 60,40 % |
| iShares S&P 500 | 2,38 % | 0,24 % | 29,01 % | 59,98 % |
Comments by Midas for this prediction
In the thread Monopar Therapeutics Inc. diskutieren
Buy Monopar Therapeutics Inc.